Application of Da Vinci robotic surgery system in cervical cancer: A single institution experience of 557 cases

Li, Jinjin; Gong, Xue; Li, Pujun; Xiao, Lin; Chang, Xiaoxia; Ouyang, Xiping; Tang, Junying

doi:10.1016/j.asjsur.2021.07.052

Cited by 8 publications

(9 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Comparable OS, DFS and recurrence rates for open and robotic radical hysterectomies were shown in several reports, thus demonstrating the safety of robotic-assisted radical hysterectomies [ 25 , 29 , 30 , 31 , 32 , 33 ]. Leitao et al showed, in their recent systematic review and meta-analysis of cancer outcomes, similar OS and DFS rates for robotic-assisted and laparoscopic surgery [1.01 (0.56, 1.80), p = 0.98] or open [1.18 (0.99, 1.41), p = 0.06] [ 33 ].…”

Section: Surgical Treatmentmentioning

confidence: 76%

“…Comparable OS, DFS and recurrence rates for open and robotic radical hysterecto mies were shown in several reports, thus demonstrating the safety of robotic-assisted rad ical hysterectomies [25,[29][30][31][32][33]. Leitao Studies aimed at reproving the safety of minimally invasive surgery for cervical cancer have been initiated and are currently in progress.…”

Section: Surgical Treatmentmentioning

confidence: 93%

“…Comparable OS, DFS and recurrence rates for open and robotic radical hysterectomies were shown in several reports, thus demonstrating the safety of robotic-assisted radical hysterectomies [25,[29][30][31][32][33]. Leitao The Robot-assisted Approach to Cervical Cancer (RACC) trial, an international, randomized controlled multicenter trial, is currently in progress.…”

Section: Surgical Treatmentmentioning

confidence: 93%

See 2 more Smart Citations

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer

et al. 2023

View full text Add to dashboard Cite

Cervical cancer is still the fourth most common cancer in women throughout the world; an estimated 604,000 new cases were observed in 2020. Better knowledge of its pathogenesis, gained in recent years, has introduced new preventive and diagnostic approaches. Knowledge of its pathogenesis has made it possible to provide individualized surgical and drug treatment. In industrialized countries, cervical cancer has become a less frequent tumor entity due to the accessibility of the human papilloma virus vaccination, systematic preventive programs/early detection programs, health care infrastructure and the availability of effective therapy options. Nevertheless, globally, neither mortality nor morbidity has been significantly reduced over the past 10 years, and therapy approaches differ widely. The aim of this review is to address recent advances in the prevention, diagnostic investigation and treatment of cervical cancer globally, focusing on advances in Germany, with a view toward providing an updated overview for clinicians. The following aspects are addressed in detail: (a) the prevalence and causes of cervical cancer, (b) diagnostic tools using imaging techniques, cytology and pathology, (c) pathomechanisms and clinical symptoms of cervical cancer and (d) different treatment approaches (pharmacological, surgical and others) and their impact on outcomes.

show abstract

Section: Surgical Treatmentmentioning

confidence: 76%

“…Comparable OS, DFS and recurrence rates for open and robotic radical hysterecto mies were shown in several reports, thus demonstrating the safety of robotic-assisted rad ical hysterectomies [25,[29][30][31][32][33]. Leitao Studies aimed at reproving the safety of minimally invasive surgery for cervical cancer have been initiated and are currently in progress.…”

Section: Surgical Treatmentmentioning

confidence: 93%

“…Comparable OS, DFS and recurrence rates for open and robotic radical hysterectomies were shown in several reports, thus demonstrating the safety of robotic-assisted radical hysterectomies [25,[29][30][31][32][33]. Leitao The Robot-assisted Approach to Cervical Cancer (RACC) trial, an international, randomized controlled multicenter trial, is currently in progress.…”

Section: Surgical Treatmentmentioning

confidence: 93%

See 1 more Smart Citation

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer

et al. 2023

View full text Add to dashboard Cite

show abstract

“…A possible alternative to laparoscopic surgery could also be robotic surgery [ 55 , 56 , 57 , 58 ]. However, current evidence on this approach is not robust enough to draw a firm conclusion, and trials on this issue should be encouraged.…”

Section: Discussionmentioning

confidence: 99%

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

Chiofalo¹,

Laganà

Ghezzi

et al. 2023

IJERPH

View full text Add to dashboard Cite

Background: The aim of our study was to compare the number of lymph nodes removed during indocyanine green (ICG)-guided laparoscopic/robotic pelvic lymphadenectomy with standard systematic lymphadenectomy in endometrial cancer (EC) and cervical cancer (CC). Methods: This is a multicenter retrospective comparative study (Clinical Trial ID: NCT04246580; updated on 31 January 2023). Women affected by EC and CC who underwent laparoscopic/robotic systematic pelvic lymphadenectomy, with (cases) or without (controls) the use of ICG tracer injection within the uterine cervix, were included in the study. Results: The two groups were homogeneous for age (p = 0.08), Body Mass Index, International Federation of Gynaecology and Obstetrics (FIGO) stages (p = 0.41 for EC; p = 0.17 for CC), median estimated blood loss (p = 0.76), median operative time (p = 0.59), and perioperative complications (p = 0.66). Nevertheless, the number of lymph nodes retrieved during surgery was significantly higher (p = 0.005) in the ICG group (n = 18) compared with controls (n = 16). Conclusions: The accurate and precise dissection achieved with the use of the ICG-guided procedure was associated with a higher number of lymph nodes removed in the case of systematic pelvic lymphadenectomy for EC and CC.

show abstract

“…Abdominal radical hysterectomy (RH) with pelvic lymph node dissection (PLND) is a classic surgical procedure used for the treatment of cervical cancer, which has demonstrated definite therapeutic efficacy [7,8]. With the continuous advancement of surgical techniques and medical equipment, a growing number of radical surgeries for cervical cancer have progressed from open to minimally-invasive laparoscopic or robot-assisted laparoscopic surgery [9,10]. Although the latter offers clear advantages, such as small surgical wounds and reduced pain, it also has disadvantages, including a limited operating space [11].Minimally invasive radical hysterectomy has a higher recurrence rate and a lower disease-free survival rate than open surgery, but the postoperative quality of life is similar, and open radical hysterectomy is recommended for patients with early-stage cervical cancer [12].…”

Section: Introductionmentioning

confidence: 99%

Complications of radical hysterectomy with pelvic lymph node dissection for cervical cancer: a 10-year single-centre clinical observational study

Huang

Yuan

et al. 2022

BMC Cancer

View full text Add to dashboard Cite

Background and purpose The complications of radical surgery for cervical cancer can increase patient suffering and affect their quality of life. This retrospective study assessed the safety of radical hysterectomy (RH) with pelvic lymph node dissection (PLND) by observing the complications of patients with cervical cancer who underwent this procedure in a single centre over 10 years. Our findings may provide experience and evidence for preventing and reducing complications. Methods A total of 2226 cervical cancer patients who met the inclusion criteria were enrolled. All patients underwent RH + PLND. Intraoperative injury to adjacent tissues and short-term and long-term complications were recorded to analyze factors associated with the occurrence of complications. Results Postoperative complications occurred in 34.41% (766/2226) of patients, including 7.68% of patients with injury to adjacent tissues, 31.45% with short-term complications, and 2.96% with long-term complications. Age, tumor size, invasion depth, parametrial invasion, lymph vascular space invasion (LVSI), lymph node metastasis, International Federation of Gynaecology and Obstetrics (FIGO) stage, and surgical procedure were closely associated with the postoperative complications of RH + PLND (P < 0.05). Conclusions The results of this study showed that RH + PLND for cervical cancer is safe and practical. Patients aged 40–60 years, with tumors ≥ 4 cm, invasion depth ≥ 2/3, parametrial invasion, LVSI, lymph node metastasis, FIGO stage > IB2, and who underwent open surgery were more prone to complications.

show abstract

Application of Da Vinci robotic surgery system in cervical cancer: A single institution experience of 557 cases

Cited by 8 publications

References 23 publications

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

Complications of radical hysterectomy with pelvic lymph node dissection for cervical cancer: a 10-year single-centre clinical observational study

Contact Info

Product

Resources

About